Iżrael - Ingliż - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Iżrael - Ingliż - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: triethyl citrate; iron oxide red; magnesium stearate; sodium starch glycollate type a; titanium dioxide; methacrylic acid copolymer; purified talc; hypromellose; silicon dioxide; macrogol 6000; carmellose sodium; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.

Iżrael - Ingliż - Ministry of Health

tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - mesalazine - ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - mesalazine, quantity: 1000 mg - suppository, moulded - excipient ingredients: hard fat - treatment of ulcerative proctitis

Iżrael - Ingliż - Ministry of Health

tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 400 mg - mesalazine - mesalazine - ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes.

Iżrael - Ingliż - Ministry of Health

ferring pharmaceuticals ltd - mesalazine - granules - mesalazine 2 g/sachet - mesalazine - mesalazine - mild to moderate ulcerative colitis or crohn's disease.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - mesalazine, quantity: 800 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; purified talc; povidone; methacrylic acid copolymer; triethyl citrate; iron oxide yellow; iron oxide red; macrogol 6000 - for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - mesalazine, quantity: 400 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; magnesium stearate; purified talc; povidone; methacrylic acid copolymer; triethyl citrate; iron oxide yellow; iron oxide red; macrogol 6000 - for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.

Malasja - Ingliż - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dch auriga (malaysia) sdn. bhd. - 5-amino salicylic acid(5-asa),mesalazine -